INmune Bio INmune Bio is a clinical-stage biotechnology company that develops immunotherapies that reprogram a patient’s innate immune system. | ![]() CNS Pharmaceuticals CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of treatments for brain tumors. | ![]() Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | PLIVA PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products. | |
Founding Date | Founding Date 2015 | Founding Date 2017 | Founding Date 1781 | Founding Date 1921 |
Type | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Boca Raton, US HQ | Locations Houston, US HQ | Locations Zagreb, HR HQ Sarajevo, BA Skopje, MK Belgrade, RS | |
Employees | Employees 22100% increase | Employees 433% increase | Employees 47,4554% decrease | Employees 1,685 |
Valuation ($) | Valuation ($) 124.9 m | Valuation ($) 4.7 m | Valuation ($) 43.7 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $50k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥4.5t (FY, 2026) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($15.9m) (FY, 2025) | Net income ¥192b (FY, 2026) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 23.2m | Total funding raised N/A | Total funding raised $ 57.8m | Total funding raised N/A |

CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of treatments for brain tumors.
View company
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyPLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.
View company